Company Global Cord Blood Corporation

Equities

CORBF

KYG393421030

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Healthcare Facilities & Services

Delayed OTC Markets Other stock markets 02:32:56 2024-04-25 pm EDT			5-day change	1st Jan Change
1.25 ^USD	-7.41%		0.00%	+2.46%

2023	Global Cord Blood Corporation Announces Board Appointments	CI
2023	Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index	CI

Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Number of employees: 1,202

USD in Million	2021	Weight	2022	Weight	Delta
Cord Blood Processing 55.7 %	96	56.4 %	108	55.7 %	+11.99%
Cord Blood Storage 43.3 %	73	42.5 %	84	43.3 %	+15.29%
Donated Cord Blood for Transplantation and Research and Others 1.0 %	2	1.1 %	2	1.0 %	+0.79%

USD in Million	2021	Weight	2022	Weight	Delta
China 100.0 %	171	100.0 %	194	100.0 %	+13.27%

Managers	Title	Age	Since
Ting Zheng CEO	Chief Executive Officer	52	08-12-31
Bing Chuen Chen DFI	Director of Finance/CFO	48	08-12-31
Xin Xu CTO	Chief Tech/Sci/R&D Officer	70	04-10-31
Rui Arashiyama PRN	Corporate Officer/Principal	65	08-12-31

Members of the board	Title	Age	Since
Jennifer J. Weng BRD	Director/Board Member	56	08-12-31
Ting Zheng CEO	Chief Executive Officer	52	08-12-31
Mark Da-Jiang Chen BRD	Director/Board Member	56	08-12-31
Bing Chuen Chen DFI	Director of Finance/CFO	48	08-12-31
Siu Lui Chow BRD	Director/Board Member	63	19-10-31
Jack S. L. Chow		63	-
Ping Xu BRD	Director/Board Member	45	17-12-31
Siu Chuen Cheng BRD	Director/Board Member	50	20-02-05
Ken Lu BRD	Director/Board Member	60	09-06-29

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	134,051,610	51,488,794 ( 38.41 %)	136,899 ( 0.1021 %)	38.41 %

Name	Equities	%	Valuation
Oasis Management Co. Ltd. 10.14 %	13,582,853	10.14 %	17 M $
Pagac Iii Holding Vii Ltd. 7.094 %	9,500,000	7.094 %	12 M $
Jayhawk Capital Management LLC 4.272 %	5,721,337	4.272 %	7 M $
Atlantis Investment Management Ltd. /Hong Kong/ 0.2906 %	389,134	0.2906 %	486 418 $
Linde & Partners Kapitalrådgivning A/S 0.2414 %	323,290	0.2414 %	404 113 $
Cigogne Management SA 0.2240 %	300,000	0.2240 %	375 000 $
Hermitage Gestion Privée SA 0.0943 %	126,228	0.0943 %	157 785 $
MW Gestion SA 0.0865 %	115,840	0.0865 %	144 800 $
RhumbLine Advisers LP 0.0393 %	52,694	0.0393 %	65 868 $
Hamon Asian Advisors Ltd. 0.0327 %	43,809	0.0327 %	54 761 $

Global Cord Blood Corp.

Bank of China Tower 1 Garden Road

, Hong Kong

http://www.globalcordbloodcorporation.com

address Global Cord Blood Corporation(CORBF)

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Other Healthcare Facilities & Services

	1st Jan change	Capi.
GLOBAL CORD BLOOD CORPORATION	+2.46%	181M
CVS HEALTH CORPORATION	-14.88%	85.42B
HCA HEALTHCARE, INC.	+16.03%	84.38B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.39B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.72%	17.49B
FRESENIUS SE & CO. KGAA	-3.17%	16.44B
QUEST DIAGNOSTICS INCORPORATED	-1.77%	15.28B
FRESENIUS MEDICAL CARE AG	-0.45%	12.22B
PURE HEALTH HOLDING	-31.23%	11.98B
EUROFINS SCIENTIFIC SE	-2.51%	11.71B

Other Healthcare Facilities & Services